Balasa Dinverno & Foltz LLC Bristol Myers Squibb CO Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 20,065 shares of BMY stock, worth $828,684. This represents 0.09% of its overall portfolio holdings.

Number of Shares

20,065

Previous 22,111 9.25%

Holding current value

$828,684

Previous $1.7 Million 16.27%

% of portfolio

0.09%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $265 - $157,214	-2,046 Reduced 9.25%	20,065 $1.43 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $268,548 - $295,766	3,698 Added 20.08%	22,111 $1.7 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $125,480 - $150,462	2,041 Added 12.47%	18,413 $1.35 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $383,186 - $446,705	-7,145 Reduced 30.38%	16,372 $1.02 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $9,940 - $11,644	168 Added 0.72%	23,517 $1.39 Million

Q2 2021 Jul 23, 2021	SELL	$61.91 - $67.42 $20,058 - $21,844	-324 Reduced 1.37%	23,349 $1.56 Million
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $61,535 - $69,209	-1,037 Reduced 4.2%	23,673 $1.49 Million
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $53,120 - $60,195	920 Added 3.87%	24,710 $1.53 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $56,166 - $62,239	978 Added 4.29%	23,790 $1.43 Million
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $147,575 - $172,530	-2,692 Reduced 10.56%	22,812 $1.34 Million
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $43,384 - $63,047	935 Added 3.81%	25,504 $1.42 Million
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $357,510 - $466,340	7,265 Added 41.98%	24,569 $1.58 Million
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $16,423 - $19,472	-384 Reduced 2.17%	17,304 $877,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $37,480 - $41,445	-840 Reduced 4.53%	17,688 $802,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $42,367 - $50,518	-939 Reduced 4.82%	18,528 $884,000
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $203,719 - $264,174	-4,178 Reduced 17.67%	19,467 $1.01 Million
Q3 2018 Oct 24, 2018	SELL	$55.19 - $62.25 $14,183 - $15,998	-257 Reduced 1.08%	23,645 $1.47 Million
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $66,952 - $83,448	-1,325 Reduced 5.25%	23,902 $1.32 Million
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $18,575 - $21,383	-310 Reduced 1.21%	25,227 $1.6 Million
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $19,960 - $21,761	-333 Reduced 1.29%	25,537 $1.57 Million
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $1.43 Million - $1.65 Million	25,870	25,870 $1.65 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.8B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Bristol Myers Squibb CO Transaction History